EventosVitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms31 de enero de 2022
EventosThe Vitro S.A. SARS-CoV-2 kits are able to detect and identify the Omicron variant.20 de diciembre de 2021